You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

THYRO-TABS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Thyro-tabs, and what generic alternatives are available?

Thyro-tabs is a drug marketed by Alvogen and is included in one NDA.

The generic ingredient in THYRO-TABS is levothyroxine sodium. There are ten drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Thyro-tabs

A generic version of THYRO-TABS was approved as levothyroxine sodium by MYLAN on June 5th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for THYRO-TABS?
  • What are the global sales for THYRO-TABS?
  • What is Average Wholesale Price for THYRO-TABS?
Drug patent expirations by year for THYRO-TABS
Pharmacology for THYRO-TABS
Drug Classl-Thyroxine

US Patents and Regulatory Information for THYRO-TABS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen THYRO-TABS levothyroxine sodium TABLET;ORAL 021116-001 Oct 24, 2002 AB1,AB2,AB3,AB4 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alvogen THYRO-TABS levothyroxine sodium TABLET;ORAL 021116-005 Oct 24, 2002 AB1,AB2,AB3,AB4 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alvogen THYRO-TABS levothyroxine sodium TABLET;ORAL 021116-010 Oct 24, 2002 AB1,AB2,AB3,AB4 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alvogen THYRO-TABS levothyroxine sodium TABLET;ORAL 021116-009 Oct 24, 2002 AB1,AB2,AB3,AB4 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alvogen THYRO-TABS levothyroxine sodium TABLET;ORAL 021116-012 Dec 7, 2004 AB1,AB2,AB3,AB4 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.